IPO Boutique

Harvard Apparatus Regenerative Technology IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Harvard Apparatus Regenerative Technology, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Harvard Apparatus Regenerative TechnologyHBIO -
NASDAQ
$10.00-$12.00 $0.00 $0.0018.7 million
Summer Street Research Partners
Co-Manager(s):
Filing(s):

Filed 2012-12-11



About Harvard Apparatus Regenerative Technology (adapted from Harvard Apparatus Regenerative Technology prospectus):
They are a clinical stage regenerative medicine company developing life-saving medical devices.

This description is adapted from Harvard HART prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Harvard HART "HBIO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved